Annual Current Liabilities
$87.78 M
-$21.01 M-19.31%
December 31, 2024
Summary
- As of March 5, 2025, CRSP annual total current liabilities is $87.78 million, with the most recent change of -$21.01 million (-19.31%) on December 31, 2024.
- During the last 3 years, CRSP annual current liabilities has fallen by -$32.10 million (-26.78%).
- CRSP annual current liabilities is now -27.52% below its all-time high of $121.11 million, reached on December 31, 2022.
Performance
CRSP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$87.78 M
-$2.03 M-2.26%
December 31, 2024
Summary
- As of March 5, 2025, CRSP quarterly total current liabilities is $87.78 million, with the most recent change of -$2.03 million (-2.26%) on December 31, 2024.
- Over the past year, CRSP quarterly current liabilities has dropped by -$40.04 million (-31.33%).
- CRSP quarterly current liabilities is now -41.82% below its all-time high of $150.87 million, reached on September 30, 2022.
Performance
CRSP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CRSP Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.3% | -31.3% |
| 3 y3 years | -26.8% | -31.3% |
| 5 y5 years | +53.7% | -31.3% |
CRSP Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.5% | at low | -41.8% | at low |
| 5 y | 5-year | -27.5% | +53.7% | -41.8% | +59.4% |
| alltime | all time | -27.5% | +3990.5% | -41.8% | +764.4% |
CRISPR Therapeutics AG Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $87.78 M(-19.3%) | $87.78 M(-2.3%) |
| Sep 2024 | - | $89.81 M(-29.7%) |
| Jun 2024 | - | $127.82 M(+7.4%) |
| Mar 2024 | - | $118.99 M(+9.4%) |
| Dec 2023 | $108.79 M(-10.2%) | $108.79 M(-2.2%) |
| Sep 2023 | - | $111.23 M(-16.3%) |
| Jun 2023 | - | $132.84 M(-9.5%) |
| Mar 2023 | - | $146.79 M(+21.2%) |
| Dec 2022 | $121.11 M(+1.0%) | $121.11 M(-19.7%) |
| Sep 2022 | - | $150.87 M(+25.8%) |
| Jun 2022 | - | $119.96 M(+5.5%) |
| Mar 2022 | - | $113.70 M(-5.2%) |
| Dec 2021 | $119.88 M(+27.2%) | $119.88 M(+24.6%) |
| Sep 2021 | - | $96.21 M(-3.7%) |
| Jun 2021 | - | $99.92 M(+20.3%) |
| Mar 2021 | - | $83.09 M(-11.8%) |
| Dec 2020 | $94.26 M | $94.26 M(+12.0%) |
| Sep 2020 | - | $84.15 M(+12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $74.50 M(+35.3%) |
| Mar 2020 | - | $55.09 M(-3.5%) |
| Dec 2019 | $57.11 M(+105.8%) | $57.11 M(-28.4%) |
| Sep 2019 | - | $79.78 M(+154.0%) |
| Jun 2019 | - | $31.41 M(+10.6%) |
| Mar 2019 | - | $28.40 M(+2.3%) |
| Dec 2018 | $27.75 M(+91.2%) | $27.75 M(-14.0%) |
| Sep 2018 | - | $32.28 M(+74.7%) |
| Jun 2018 | - | $18.48 M(+28.4%) |
| Mar 2018 | - | $14.39 M(-0.8%) |
| Dec 2017 | $14.51 M(-34.0%) | $14.51 M(+19.8%) |
| Sep 2017 | - | $12.12 M(-23.4%) |
| Jun 2017 | - | $15.81 M(-6.5%) |
| Mar 2017 | - | $16.91 M(-23.1%) |
| Dec 2016 | $22.00 M(+116.6%) | $22.00 M(-71.8%) |
| Sep 2016 | - | $78.10 M(-3.1%) |
| Jun 2016 | - | $80.60 M(+693.7%) |
| Dec 2015 | $10.15 M(+373.2%) | $10.15 M |
| Dec 2014 | $2.15 M | - |
FAQ
- What is CRISPR Therapeutics AG annual total current liabilities?
- What is the all time high annual current liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual current liabilities year-on-year change?
- What is CRISPR Therapeutics AG quarterly total current liabilities?
- What is the all time high quarterly current liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly current liabilities year-on-year change?
What is CRISPR Therapeutics AG annual total current liabilities?
The current annual current liabilities of CRSP is $87.78 M
What is the all time high annual current liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual total current liabilities is $121.11 M
What is CRISPR Therapeutics AG annual current liabilities year-on-year change?
Over the past year, CRSP annual total current liabilities has changed by -$21.01 M (-19.31%)
What is CRISPR Therapeutics AG quarterly total current liabilities?
The current quarterly current liabilities of CRSP is $87.78 M
What is the all time high quarterly current liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly total current liabilities is $150.87 M
What is CRISPR Therapeutics AG quarterly current liabilities year-on-year change?
Over the past year, CRSP quarterly total current liabilities has changed by -$40.04 M (-31.33%)